Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014893
Filing Date
2023-08-14
Accepted
2023-08-14 16:45:39
Documents
108
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gdnsf-20230630x10q.htm   iXBRL 10-Q 1651904
2 EX-31.1 gdnsf-20230630xex31d1.htm EX-31.1 15604
3 EX-31.2 gdnsf-20230630xex31d2.htm EX-31.2 14094
4 EX-32.1 gdnsf-20230630xex32d1.htm EX-32.1 8607
  Complete submission text file 0001558370-23-014893.txt   8806941

Data Files

Seq Description Document Type Size
5 EX-101.SCH gdnsf-20230630.xsd EX-101.SCH 81274
6 EX-101.CAL gdnsf-20230630_cal.xml EX-101.CAL 83898
7 EX-101.DEF gdnsf-20230630_def.xml EX-101.DEF 279885
8 EX-101.LAB gdnsf-20230630_lab.xml EX-101.LAB 607999
9 EX-101.PRE gdnsf-20230630_pre.xml EX-101.PRE 495393
102 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20230630x10q_htm.xml XML 1600787
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 231171427
SIC: 2834 Pharmaceutical Preparations